Waystar Holding Corp. Stock Price, News & Analysis

Waystar (Nasdaq: WAY), a healthcare payment software provider, has announced that CEO Matt Hawkins will present at the upcoming Goldman Sachs Communacopia + Technology Conference. The presentation is scheduled for September 10, 2025, at 3:05 p.m. PT.

Investors can access a live webcast of the presentation through Waystar's Investor Relations website. A recording of the presentation will be made available on the same platform following the event.

Waystar (Nasdaq: WAY), a healthcare payment software provider, has secured multiple Gold Stevie® Awards in 2025, including Healthcare Company of the Year and Top-Ranked AI Software Platform for Waystar AltitudeAI™. The company's Auth Accelerate solution achieved industry-leading auto-approval rates exceeding 90% for prior authorizations.

Waystar AltitudeAI™, launched in 2025, has demonstrated significant impact with a 70% increase in appeal productivity and efficiency gains equivalent to 10 full-time employees for mid-size health systems. The company also announced plans to acquire Iodine Software to enhance its AI capabilities in clinical intelligence.

Waystar (Nasdaq: WAY), a healthcare payment software provider, has successfully repriced its first lien term loan due October 2029. The company secured a 25-basis-point reduction in interest rate to adjusted SOFR +2.00%. Additionally, Waystar will add $250 million of incremental term loans under the same terms to help fund the pending Iodine Software acquisition.

This marks Waystar's third successful repricing since its June 2024 IPO, resulting in a total reduction of 211 basis points in borrowing costs. The company's debt rating and stable outlook have been reaffirmed by major rating agencies S&P, Moody's, and Fitch.

Waystar (NASDAQ:WAY), a healthcare payment software provider, reported strong Q2 2025 financial results with revenue reaching $270.7 million, up 15% year-over-year. The company achieved a net income of $32.2 million with a 12% margin and an adjusted EBITDA of $112.6 million with a 42% margin.

Key performance metrics include 1,268 clients contributing over $100,000 in LTM revenue (up 14% YoY) and a net revenue retention rate of 115%. The company raised its full-year 2025 guidance, projecting revenue between $1.030-1.042 billion and adjusted EBITDA between $418-426 million.

Waystar also announced an agreement to acquire Iodine Software, an AI-powered clinical intelligence company, expected to expand their market reach and be accretive to their financial profile.

Waystar (NASDAQ:WAY) has announced a definitive agreement to acquire Iodine Software for a total enterprise value of $1.25 billion. The acquisition will be funded through a 50/50 mix of cash and stock, with Iodine shareholders receiving approximately 8% ownership of the combined company.

The strategic acquisition aims to enhance Waystar's AI capabilities in healthcare payments, expanding its total addressable market by more than 15%. The deal is expected to be immediately accretive to gross margin and adjusted EBITDA margin, with revenue growth and earnings benefits anticipated by 2027. The company has identified over $15 million in run-rate cost synergies to be realized within 18-24 months post-closing.

Additionally, Waystar reported preliminary Q2 2025 revenue of approximately $271 million, representing 15% year-over-year growth. The transaction is expected to close by year-end 2025.

Waystar Holding Corp. (Nasdaq: WAY), a healthcare payment software provider, has scheduled its Q2 2025 earnings release for July 30, 2025, after market close. The company will host a conference call at 4:30 p.m. Eastern Time on the same day to discuss the financial results.

Investors can access the live audio webcast through Waystar's investor relations website at investors.waystar.com/news-events/events. An archived version of the webcast will be available for those unable to attend the live event.

Waystar (WAY) released a Forrester Consulting study highlighting AI's critical role in healthcare revenue cycle management (RCM). The study reveals that 82% of healthcare leaders consider AI integral to RCM operations, with 70% marking it as a top priority. AI implementations are delivering significant performance improvements of 13-37% across key metrics including claim accuracy, denial prevention, and payment speed. Trust in AI has grown substantially, with 60% of decision-makers reporting increased confidence post-implementation. The majority of healthcare organizations prefer established RCM software partners for AI capabilities over new vendors, citing faster implementation and proven security. The study, based on over 300 healthcare leaders' responses, indicates a clear trend toward strategic AI adoption, particularly in payer-facing workflows.

Waystar Holding Corp (Nasdaq: WAY), a healthcare payment software provider, has appointed two distinguished leaders to its Board of Directors. Aashima Gupta, Global Director of Healthcare Strategy and Solutions at Google Cloud, brings expertise in AI strategy and digital healthcare transformation. She currently serves on multiple boards including Neogen and was named among Modern Healthcare's Top 10 Executives to Watch in 2024. Michael Roman, former Executive Chairman and CEO of 3M, joins with nearly 40 years of experience leading a $32 billion global technology company. Roman, who currently serves on Abbott Laboratories' board, brings strategic leadership and operational excellence, particularly notable given 3M's significant healthcare division which represents 25% of its revenue.

Waystar (Nasdaq: WAY), a healthcare payment software provider, has been recognized as a 2025-2026 Best Company to Work For by U.S. News & World Report. The company ranked in the top 6% among 5,000 evaluated public companies and within the top 25% in both the Health Care and Research sector and the West region.

The evaluation was based on six key factors: pay and benefits, work-life balance, job stability, physical and psychological comfort, belongingness, and career development. CEO Matt Hawkins highlighted the company's culture of innovation and commitment to simplifying healthcare payments for over one million providers nationwide. Waystar has also received recognition from Fortune's Great Place to Work®, Becker's Healthcare, and the Women Tech Council's Shatter List.